4.6 Article

Antimicrobial Photodynamic Therapy in the Control of COVID-19

Journal

ANTIBIOTICS-BASEL
Volume 9, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/antibiotics9060320

Keywords

antimicrobial photodynamic therapy; coronaviruses; SARS-CoV-2; COVID-19; control; disinfection

Funding

  1. University of Aveiro
  2. FCT/MCTES through national funds (PIDDAC) [UID/AMB/50017 - POCI-01-0145-FEDER-007638, UIDB/50006/2020, FCT-PTDC/ASPPES/29576/2017]
  3. FEDER, within the PT2020 Partnership Agreement
  4. Compete 2020

Ask authors/readers for more resources

Antimicrobial photodynamic therapy (aPDT), using well known, safe and cost-effective photosensitizers, such as phenothiazines, e.g., methylene blue (MB), or porphyrins, e.g., protoporphyrin-IX (PP-IX), might help to mitigate the COVID-19 either to prevent infections or to develop photoactive fabrics (e.g., masks, suits, gloves) to disinfect surfaces, air and wastewater, under artificial light and/or natural sunlight.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available